Clostridium difficile Infection News
- Fecal Transplant Trial for IBS Shows Lasting Response
- C. diff: How Did a Community Hospital Cut Infections by 77%?
- DDW 2022 Fidaxomicin Favored Over Vancomycin in Real-World C diff Study
- DDW 2022 Bacterial Cocktail, Spores Counter Recurrent C difficile
- Understanding Toxin Testing Results for C diff
- Novel Antibiotic Shows Promise for C diff Infection
- Black, Senior Patients More Likely to Get Unneeded Antibiotics
- Asymptomatic C. difficile Carriers May Infect Their Families
- Engineered Bacteria Could Protect Gut from Antibiotics: Study
- What's the Future of Microbiome Therapies in CDI, Cancer?
- Aerosolized Hydrogen Peroxide Can Significantly Reduce C. difficile Infections
- Are 'Antibiotic Diets' Good Practice?
- C difficile Vaccine: CLOVER Trial Shows Mixed Results
- ECCO 2022 'Superdonor' Samples Don't Increase FMT Success in UC
- C Difficile: New Vancomycin-Resistant Strains Raise Concerns
- Donor-Derived Strains Predict FMT Response for Ulcerative Colitis
- 'Forgotten Antibiotic' Better Than Cefotaxime in Febrile UTIs?
- ACG 2021 A Pill for C difficile Works by Increasing Microbiome Diversity
- Fecal Transplants May Improve Resistance to Melanoma Therapy
- Gut Bacteria May Fuel Prostate Cancer Treatment Resistance